XML 25 R8.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 24, 2020
Jun. 26, 2019
Cash flows from operating activities:    
Net income (loss) $ (13,952) $ 49,729
Adjustments to reconcile net income (loss) to cash flows provided by (used in) operating activities:    
Depreciation and amortization 8,204 11,281
Operating (gains), losses and other charges, net 3,100 (35,368)
Loss on interest rate swap derivatives 11,466 0
Amortization of deferred financing costs 340 304
Gains on investments (91) (106)
Losses (gains) on termination of leases 53 (83)
Deferred income tax expense (benefit) (3,705) 4,944
Share-based compensation expense (benefit) (26) 4,966
Changes in assets and liabilities:    
Receivables 9,342 7,545
Inventories 175 646
Other current assets (2,593) (4,748)
Other assets 106 (2,392)
Operating lease assets and liabilities 1,769 (481)
Accounts payable (537) (2,190)
Accrued payroll (11,519) (4,597)
Accrued taxes (712) (952)
Other accrued liabilities (6,551) (3,840)
Other noncurrent liabilities (2,827) 497
Net cash flows provided by (used in) operating activities (7,958) 25,155
Cash flows from investing activities:    
Capital expenditures (4,476) (6,777)
Acquisition of restaurants and real estate 0 (4,706)
Deposits on acquisitions of real estate 0 (4,320)
Proceeds from sales of restaurants, real estate and other assets 2,208 47,938
Investment purchases (1,400) (1,300)
Proceeds from sale of investments 2,900 0
Collections on notes receivable 918 858
Issuance of notes receivable (484) (718)
Net cash flows provided by (used in) investing activities (334) 30,975
Cash flows from financing activities:    
Revolver borrowings 130,000 66,500
Revolver payments (63,000) (82,000)
Long-term debt payments (594) (1,547)
Proceeds from exercise of stock options 66 550
Tax withholding on share-based payments (3,036) (3,178)
Deferred financing costs (982) 0
Purchase of treasury stock (36,008) (37,266)
Net bank overdrafts (449) (1,923)
Net cash flows provided by (used in) financing activities 25,997 (58,864)
Increase (decrease) in cash and cash equivalents 17,705 (2,734)
Cash and cash equivalents at beginning of period 3,372 5,026
Cash and cash equivalents at end of period $ 21,077 $ 2,292